dpp 4 inhibitors vs glp 1 dpp-4_inhibitors [TUSOM DPP-4 inhibitors and GLP-1RAs: cardiovascular

Unfortunately, most of the experiments have evaluated GHRP-2 or GHRP-6 with full-length GHRH rather than Sermorelin, but such results are valuable for future research

Manoharan RR, Prasad A, Pospil P, Kzhyshkowska J

Primary Uses : While initially approved for HIV-associated lipodystrophy, Tesamorelin has gained popularity for its potential benefits in reducing abdominal fat, improving metabolic health, and even promoting cognitive function in certain populations

The agency stated that the companies promoted compounded versions of GLP-1 medications in ways that implied sameness with FDA approved drugs and obscured the source of the products, including through branding practices that suggested the telehealth firms themselves were the compounders

This opens protocol design options and raises mechanistic questions about how a 15-amino-acid peptide survives the GI tract with sufficient intact molecule to produce systemic effects (or whether the observed effects are primarily local GI-tract actions)